Skip to main content
Premium Trial:

Request an Annual Quote

Mark Stevenson, David Hoffmeister, Claude Benchimol, Richard Hughes, Graham Mullis, Robert Saltmarsh, Nicholas Venuto, David Johnston

Premium
Mark Stevenson has been promoted to the position of president and chief operating officer of Applied Biosystems and senior vice president of Applera, ABI’s parent corporation.
 
Stevenson was promoted in July to executive vice president, after serving 15 months as president of the Molecular and Cellular Biology Division. Concurrent with that promotion, ABI had split the MCB Division into two groups: MCB Systems and MCB Consumables.
 
Before taking over at the helm of the MCB division, Stevenson was president of ABI’s Applied Markets division. He has been with the firm since 1998 and has held several management positions with the company.
 
Stevenson will replace Tony White, chairman, president, and CEO of Applera, who has served as interim president of ABI since October 2006, when Cathy Burzik resigned.
 

 
Invitrogen has given company CFO David Hoffmeister a raise in base salary to $475,000, and has raised VP of R&D Claude Benchimol’s salary to $420,000, according to a filing with the US Securities and Exchange Commission. The raises will take effect at the beginning of the year, the company said.
 

 
Richard Hughes of the London-based healthcare and diagnostics company Lab21 has been bumped up to head of sales and marketing and has been elected to sit on the company’s executive management team. Hughes will report directly to company CEO Graham Mullis.
 

 
Robert Saltmarsh, VP and CFO at Nanogen, plans to retire at the end of February, the company stated in an SEC filing. Nanogen also said that Nicholas Venuto, who is currently executive director of finance, will take over Saltmarsh’s duties in both positions. Nanogen also has given Venuto a hike in base salary to $220,000 and granted him the option to buy 100,000 shares of the company’s common stock.
 

 
Gene Express has appointed David Johnston to its scientific advisory board. Johnston is VP and chief scientific officer at Esoterix Clinical Trials Services, a division of Laboratory Corporation of America. Johnston has also formerly held various R&D leadership positions at LabCorp.

Filed under

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.